2008RetinaRequires access

COMBINATION TREATMENT WITH REDUCED-FLUENCE PHOTODYNAMIC THERAPY AND INTRAVITREAL INJECTION OF TRIAMCINOLONE FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN MACULAR DEGENERATION

Christopher N. Singh, David A. Saperstein

Open publisher page 19 citations

Abstract

In Brief Purpose: To evaluate combination treatment with reduced-fluence photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVT) injection for choroidal neovascularization (CNV) in age-related macular degeneration (AMD). Methods: This is a retrospective consecutive case series of 23 previously untreated eyes of 22 patients with subfoveal CNV secondary to AMD. Six eyes were treated with 50 J/cm2; 8, with 40 J/cm2; and 9, with 25 J/cm2. PDT was immediately followed by a 4-mg IVT injection. Patients were observed for 6 months at 6-week intervals. Results: The 50 J/cm2 subset lost a mean of 2.2 lines of Snellen visual acuity at the 6-month follow-up compared with a 1-line lost in the 40 J/cm2 subset and a 0.9-line gain in the 25 J/cm2 subset. In the 50 J/cm2 subset, 60% lost ≤3 lines of Snellen visual acuity, 33% gained ≥0 line, and 33% gained ≥3 lines. In the 40 J/cm2 subset, 75% lost ≤3 lines of Snellen visual acuity, 50% gained ≥0 line, and 25% gained ≥3 lines. In the 25 J/cm2 subset, 89% lost ≤3 lines of Snellen visual acuity, 56% gained ≥0 line, and 33% gained ≥3 lines. Fifty percent of the 50 J/cm2 subset, 50% of the 40 J/cm2 subset, and 33% of the 25 J/cm2 subset required retreatment by 6 months. Conclusion: Although the sample in this study was small, there was a dose–response trend toward better visual outcomes and fewer treatments in the group treated with IVT injection and reduced-fluence PDT. This study along with other previously reported work suggests that studies using PDT in combination treatment for CNV should consider adding a reduced-fluence PDT arm. In a study of combination treatment with reduced-fluence photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVT) injection for choroidal neovascularization (CNV) in age-related macular degeneration, there was a dose–response trend toward better visual outcomes and fewer treatments in the group treated with IVT injection and reduced-fluence PDT. This study along with other previously reported work suggests that studies using PDT in combination treatment for CNV should consider adding a reduced-fluence PDT arm.

About this research paper

What this paper is about

In Brief Purpose: To evaluate combination treatment with reduced-fluence photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVT) injection for choroidal neovascularization (CNV) in age-related macular degeneration (AMD). Methods: This is a retrospective consecutive case series of 23 previously untreated eyes of 22 patients with subfoveal CNV secondary to AMD. Six eyes were treated with 50 J/cm2; 8, with 40 J/cm2; and 9, with 25 J/cm2. PDT was immediately followed by a 4-mg IVT injection. Patients were observed for 6 months at 6-week intervals. Results: The 50 J/cm2 subset lost a mean of 2.2 lines of Snellen visual acuity at the 6-month follow-up compared with a 1-line lost in the 40 J/cm2 subset and a 0.9-line gain in the 25 J/cm2 subset. In the 50 J/cm2 subset, 60% lost ≤3 lines of Snellen visual acuity, 33% gained ≥0 line, and 33% gained ≥3 lines. In the 40 J/cm2 subset, 75% lost ≤3 lines of Snellen visual acuity, 50% gained ≥0 line, and 25% gained ≥3 lines. In the 25 J/cm2 subset, 89% lost ≤3 lines of Snellen visual acuity, 56% gained ≥0 line, and 33% gained ≥3 lines. Fifty percent of the 50 J/cm2 subset, 50% of the 40 J/cm2 subset, and 33% of the 25 J/cm2 subset required retreatment by 6 months. Conclusion: Although the sample in this study was small, there was a dose–response trend toward better visual outcomes and fewer treatments in the group treated with IVT injection and reduced-fluence PDT. This study along with other previously reported work suggests that studies using PDT in combination treatment for CNV should consider adding a reduced-fluence PDT arm. In a study of combination treatment with reduced-fluence photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVT) injection for choroidal neovascularization (CNV) in age-related macular degeneration, there was a dose–response trend toward better visual outcomes and fewer treatments in the group treated with IVT injection and reduced-fluence PDT. This study along with other previously reported work suggests that studies using PDT in combination treatment for CNV should consider adding a reduced-fluence PDT arm.

Why it matters

OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In Brief Purpose: To evaluate combination treatment with reduced-fluence photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVT) injection for choroidal neovascularization (CNV) in age-related macular degeneration (AMD). Methods: This is a retrospective consecutive case series of 23 previously untreated eyes of 22 patients with subfoveal CNV secondary to AMD. Six eyes were treated with 50 J/cm2; 8, with 40 J/cm2; and 9, with 25 J/cm2. PDT was immediately followed by a 4-mg IVT injection. Patients were observed for 6 months at 6-week intervals. Results: The 50 J/cm2 subset lost a mean of 2.2 lines of Snellen visual acuity at the 6-month follow-up compared with a 1-line lost in the 40 J/cm2 subset and a 0.9-line gain in the 25 J/cm2 subset. In the 50 J/cm2 subset, 60% lost ≤3 lines of Snellen visual acuity, 33% gained ≥0 line, and 33% gained ≥3 lines. In the 40 J/cm2 subset, 75% lost ≤3 lines of Snellen visual acuity, 50% gained ≥0 line, and 25% gained ≥3 lines. In the 25 J/cm2 subset, 89% lost ≤3 lines of Snellen visual acuity, 56% gained ≥0 line, and 33% gained ≥3 lines. Fifty percent of the 50 J/cm2 subset, 50% of the 40 J/cm2 subset, and 33% of the 25 J/cm2 subset required retreatment by 6 months. Conclusion: Although the sample in this study was small, there was a dose–response trend toward better visual outcomes and fewer treatments in the group treated with IVT injection and reduced-fluence PDT. This study along with other previously reported work suggests that studies using PDT in combination treatment for CNV should consider adding a reduced-fluence PDT arm. In a study of combination treatment with reduced-fluence photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVT) injection for choroidal neovascularization (CNV) in age-related macular degeneration, there was a dose–response trend toward better visual outcomes and fewer treatments in the group treated with IVT injection and reduced-fluence PDT. This study along with other previously reported work suggests that studies using PDT in combination treatment for CNV should consider adding a reduced-fluence PDT arm.

Key concepts: Choroidal neovascularization, Macular degeneration, Photodynamic therapy, Ophthalmology, Medicine, Triamcinolone acetonide, Neovascularization, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
COMBINATION TREATMENT WITH REDUCED-FLUENCE PHOTODYNAMIC THERAPY AND INTRAVITREAL INJECTION OF TRIAMCINOLONE FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN MACULAR DEGENERATION — Research Paper | ScholarLens